We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Light-Sensitive Nanoparticles Designed for Smart Drug Release

By LabMedica International staff writers
Posted on 14 Feb 2018
A novel type of "smart" nanoparticles responds to light of specific wavelengths that causes the particles to assemble or disassemble, which enables the dynamic organization of the nanoparticles for in vitro drug release.

The ability to dynamically organize functional nanoparticles (NPs) via the use of environmental triggers (temperature, pH, light, or solvent polarity) opens up important perspectives for rapid and convenient construction of a rich variety of complex assemblies and materials with new structures and functionalities.

In a study published in the January 31, 2018, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences, investigators at the Georgia Institute of Technology (Atlanta, USA) described an unconventional strategy for crafting stable "hairy" NPs with light-enabled reversible and reliable self-assembly and tunable optical properties.

The "hairy" nanoparticles were fabricated around a tiny core of beta-cyclodextrin from which polymer chains of poly(acrylicacid)-block-poly(7-methylacryloyloxy-4-methylcoumarin) (PAA-b-PMAMC) were grown. More...
This compound attracted water-soluble metal precursors, which utilized the space within the polymer hairs as nano-reactors to form gold nanoparticles. The investigators then added hairs made from the light sensitive hydrophobic monomer MAMC.

Light at a wavelength of 365 nanometers induced the nanoparticles to self-assemble through a photo-dimerization process, while the process was reversed when the particles were exposed to light at 254 nanometers.

“Under light, the assemblies of photo-sensitive nanoparticles separate over a period of hours at a rate that can be controlled by the intensity and wavelength of the light,” said senior author Dr. Zhiqun Lin, professor of materials science and engineering at the Georgia Institute of Technology. “Because the disassembly can be turned on and off at will, we could provide a timed release of the drug by controlling the short-wavelength light exposure. Once the polymer chains from adjacent gold nanoparticles begin to photo-crosslink, they bring nanoparticles together via a self-assembly process to generate large assemblies of nanoparticles. This process is completely reversible and can be repeated in many cycles.”

“We envision that these photo-responsive polymer-capped gold nanoparticles could one day serve as nano-carriers for drug delivery into the body using our robust and reversible process for assembly and disassembly,” said Dr. Lin. “Used in cancer therapy, this process could increase the impact of a treatment by heating the cancer cells while introducing the drug compound into the tumor.”

Related Links:
Georgia Institute of Technology


New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.